{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:30:11Z","timestamp":1768415411231,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:00:00Z","timestamp":1355875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00125-012-2801-0","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T13:54:57Z","timestamp":1355838897000},"page":"553-562","source":"Crossref","is-referenced-by-count":56,"title":["Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin\u2013angiotensin system in mice"],"prefix":"10.1007","volume":"56","author":[{"given":"Q.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. J.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. S.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"key":"2801_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/138945011793591653","volume":"12","author":"BJ Boucher","year":"2011","unstructured":"Boucher BJ (2011) Vitamin D insufficiency and diabetes risks. Curr Drug Targets 12:61\u201387","journal-title":"Curr Drug Targets"},{"key":"2801_CR2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/BF00422375","volume":"38","author":"BJ Boucher","year":"1995","unstructured":"Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38:1239\u20131245","journal-title":"Diabetologia"},{"key":"2801_CR3","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2337\/db08-0593","volume":"57","author":"NG Forouhi","year":"2008","unstructured":"Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ (2008) Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990\u20132000. Diabetes 57:2619\u20132625","journal-title":"Diabetes"},{"key":"2801_CR4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","volume":"79","author":"KC Chiu","year":"2004","unstructured":"Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79:820\u2013825","journal-title":"Am J Clin Nutr"},{"key":"2801_CR5","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2337\/db11-0465","volume":"60","author":"S Kayaniyil","year":"2011","unstructured":"Kayaniyil S, Retnakaran R, Harris SB et al (2011) Prospective associations of vitamin D with beta-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes 60:2947\u20132953","journal-title":"Diabetes"},{"key":"2801_CR6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.metabol.2011.09.007","volume":"61","author":"A Vaidya","year":"2012","unstructured":"Vaidya A, Williams JS (2012) The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism 61:450\u2013458","journal-title":"Metabolism"},{"key":"2801_CR7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2265.2011.03991.x","volume":"74","author":"A Vaidya","year":"2011","unstructured":"Vaidya A, Sun B, Forman JP et al (2011) The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians. Clin Endocrinol (Oxf) 74:783\u2013790","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2801_CR8","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/diabetes.51.7.2294","volume":"51","author":"BW Ogunkolade","year":"2002","unstructured":"Ogunkolade BW, Boucher BJ, Prahl JM et al (2002) Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51:2294\u20132300","journal-title":"Diabetes"},{"key":"2801_CR9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6250216","volume":"209","author":"AW Norman","year":"1980","unstructured":"Norman AW, Frankel JB, Heldt AM, Grodsky GM (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209:823\u2013825","journal-title":"Science"},{"key":"2801_CR10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1096\/fj.02-0424fje","volume":"17","author":"U Zeitz","year":"2003","unstructured":"Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG (2003) Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17:509\u2013511","journal-title":"FASEB J"},{"key":"2801_CR11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF03350185","volume":"11","author":"H Labriji-Mestaghanmi","year":"1988","unstructured":"Labriji-Mestaghanmi H, Billaudel B, Garnier PE, Malaisse WJ, Sutter BC (1988) Vitamin D and pancreatic islet function. I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion. J Endocrinol Invest 11:577\u2013584","journal-title":"J Endocrinol Invest"},{"key":"2801_CR12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2005.05.051","volume":"46","author":"H Abuissa","year":"2005","unstructured":"Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr (2005) Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 46:821\u2013826","journal-title":"J Am Coll Cardiol"},{"key":"2801_CR13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00125-003-1295-1","volume":"47","author":"T Lau","year":"2004","unstructured":"Lau T, Carlsson PO, Leung PS (2004) Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47:240\u2013248","journal-title":"Diabetologia"},{"key":"2801_CR14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/jpet.108.142703","volume":"327","author":"Q Cheng","year":"2008","unstructured":"Cheng Q, Law PK, de Gasparo M, Leung PS (2008) Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L- valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes. J Pharmacol Exp Ther 327:683\u2013691","journal-title":"J Pharmacol Exp Ther"},{"key":"2801_CR15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/diabetes.55.02.06.db05-1022","volume":"55","author":"KY Chu","year":"2006","unstructured":"Chu KY, Lau T, Carlsson PO, Leung PS (2006) Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 55:367\u2013374","journal-title":"Diabetes"},{"key":"2801_CR16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/ars.2007.1590","volume":"9","author":"KY Chu","year":"2007","unstructured":"Chu KY, Leung PS (2007) Angiotensin II type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young type 2 diabetic mice. Antioxid Redox Signal 9:869\u2013878","journal-title":"Antioxid Redox Signal"},{"key":"2801_CR17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00125-004-1485-5","volume":"47","author":"H Gerstein","year":"2004","unstructured":"Gerstein H, Yusuf S, Holman R, Bosch J, Pogue J (2004) Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia 47:1519\u20131527","journal-title":"Diabetologia"},{"key":"2801_CR18","first-page":"387","volume":"89\u201390","author":"YC Li","year":"2004","unstructured":"Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89\u201390:387\u2013392","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2801_CR19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229\u2013238","journal-title":"J Clin Invest"},{"key":"2801_CR20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.2008.101","volume":"74","author":"C Zhou","year":"2008","unstructured":"Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D (2008) Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int 74:170\u2013179","journal-title":"Kidney Int"},{"key":"2801_CR21","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","volume":"104","author":"N Bodyak","year":"2007","unstructured":"Bodyak N, Ayus JC, Achinger S et al (2007) Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A 104:16810\u201316815","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2801_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2169\/internalmedicine.38.31","volume":"38","author":"Y Kimura","year":"1999","unstructured":"Kimura Y, Kawamura M, Owada M et al (1999) Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity. Intern Med 38:31\u201335","journal-title":"Intern Med"},{"key":"2801_CR23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cca.2010.05.037","volume":"411","author":"A Tomaschitz","year":"2010","unstructured":"Tomaschitz A, Pilz S, Ritz E et al (2010) Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 411:1354\u20131360","journal-title":"Clin Chim Acta"},{"key":"2801_CR24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1470320310391922","volume":"12","author":"A Vaidya","year":"2011","unstructured":"Vaidya A, Forman JP, Hopkins PN, Seely EW, Williams JS (2011) 25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst 12:311\u2013319","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2801_CR25","doi-asserted-by":"crossref","first-page":"15896","DOI":"10.1073\/pnas.0803751105","volume":"105","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC (2008) Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A 105:15896\u201315901","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2801_CR26","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00125-011-2100-1","volume":"54","author":"Q Cheng","year":"2011","unstructured":"Cheng Q, Li YC, Boucher BJ, Leung PS (2011) A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Diabetologia 54:2077\u20132081","journal-title":"Diabetologia"},{"key":"2801_CR27","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1172\/JCI30910","volume":"117","author":"T Morioka","year":"2007","unstructured":"Morioka T, Asilmaz E, Hu J et al (2007) Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 117:2860\u20132868","journal-title":"J Clin Invest"},{"key":"2801_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/CS20100061","volume":"119","author":"V Souza-Mello","year":"2010","unstructured":"Souza-Mello V, Gregorio BM, Cardoso-de-Lemos FS, de Carvalho L, Aguila MB, Mandarim-de-Lacerda CA (2010) Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL\/6 mice fed on a very high-fat diet. Clin Sci (Lond) 119:239\u2013250","journal-title":"Clin Sci (Lond)"},{"key":"2801_CR29","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/oby.2010.11","volume":"18","author":"G Muscogiuri","year":"2010","unstructured":"Muscogiuri G, Sorice GP, Prioletta A et al (2010) 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obes (Silver Spring) 18:1906\u20131910","journal-title":"Obes (Silver Spring)"},{"key":"2801_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00394-009-0020-3","volume":"48","author":"R Jorde","year":"2009","unstructured":"Jorde R, Figenschau Y (2009) Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48:349\u2013354","journal-title":"Eur J Nutr"},{"key":"2801_CR31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa065061","volume":"355","author":"J Bosch","year":"2006","unstructured":"Bosch J, Yusuf S, Gerstein HC et al (2006) Effect of ramipril on the incidence of diabetes. N Engl J Med 355:1551\u20131562","journal-title":"N Engl J Med"},{"key":"2801_CR32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","volume":"13","author":"NS Kalupahana","year":"2012","unstructured":"Kalupahana NS, Moustaid-Moussa N (2012) The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev 13:136\u2013149","journal-title":"Obes Rev"},{"key":"2801_CR33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/01.HYP.0000040262.48405.A8","volume":"40","author":"T Ogihara","year":"2002","unstructured":"Ogihara T, Asano T, Ando K et al (2002) Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40:872\u2013879","journal-title":"Hypertension"},{"key":"2801_CR34","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1210\/en.2008-1391","volume":"150","author":"G Lastra","year":"2009","unstructured":"Lastra G, Habibi J, Whaley-Connell AT et al (2009) Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression. Endocrinology 150:2561\u20132568","journal-title":"Endocrinology"},{"key":"2801_CR35","doi-asserted-by":"crossref","first-page":"C313","DOI":"10.1152\/ajpcell.00575.2008","volume":"298","author":"KY Chu","year":"2010","unstructured":"Chu KY, Cheng Q, Chen C et al (2010) Angiotensin II exerts glucose-dependent effects on Kv currents in mouse pancreatic beta-cells via angiotensin II type 2 receptors. Am J Physiol Cell Physiol 298:C313\u2013C323","journal-title":"Am J Physiol Cell Physiol"},{"key":"2801_CR36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31\u201338","journal-title":"Kidney Int"},{"key":"2801_CR37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI0216160","volume":"110","author":"CD Sigmund","year":"2002","unstructured":"Sigmund CD (2002) Regulation of renin expression and blood pressure by vitamin D(3). J Clin Invest 110:155\u2013156","journal-title":"J Clin Invest"},{"key":"2801_CR38","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","volume":"55","author":"JP Forman","year":"2010","unstructured":"Forman JP, Williams JS, Fisher ND (2010) Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 55:1283\u20131288","journal-title":"Hypertension"},{"key":"2801_CR39","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1172\/JCI200216857","volume":"110","author":"T Kitamura","year":"2002","unstructured":"Kitamura T, Nakae J, Kitamura Y et al (2002) The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110:1839\u20131847","journal-title":"J Clin Invest"},{"key":"2801_CR40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1083\/jcb.62.1.77","volume":"62","author":"L Boquist","year":"1974","unstructured":"Boquist L, Hellman B, Lernmark A, Taljedal IB (1974) Influence of the mutation \"diabetes\" on insulin release and islet morphology in mice of different genetic backgrounds. J Cell Biol 62:77\u201389","journal-title":"J Cell Biol"},{"key":"2801_CR41","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1681\/ASN.2007121291","volume":"19","author":"A Kottgen","year":"2008","unstructured":"Kottgen A, Hwang SJ, Rampersaud E et al (2008) TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J Am Soc Nephrol 19:1989\u20131999","journal-title":"J Am Soc Nephrol"},{"key":"2801_CR42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/db08-1187","volume":"58","author":"XG Silva da","year":"2009","unstructured":"da Silva XG, Loder MK, McDonald A et al (2009) TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 58:894\u2013905","journal-title":"Diabetes"},{"key":"2801_CR43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI10582","volume":"106","author":"JE Pessin","year":"2000","unstructured":"Pessin JE, Saltiel AR (2000) Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106:165\u2013169","journal-title":"J Clin Invest"},{"key":"2801_CR44","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1152\/ajpendo.00032.2004","volume":"289","author":"AM Hennige","year":"2005","unstructured":"Hennige AM, Ozcan U, Okada T et al (2005) Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells. Am J Physiol Endocrinol Metab 289:E337\u2013E346","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2801_CR45","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/01.ATV.0000164313.17167.df","volume":"25","author":"Y Taniyama","year":"2005","unstructured":"Taniyama Y, Hitomi H, Shah A, Alexander RW, Griendling KK (2005) Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler Thromb Vasc Biol 25:1142\u20131147","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2801_CR46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ng1774","volume":"38","author":"N Hashimoto","year":"2006","unstructured":"Hashimoto N, Kido Y, Uchida T et al (2006) Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat Genet 38:589\u2013593","journal-title":"Nat Genet"},{"key":"2801_CR47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-5793(95)00809-N","volume":"370","author":"MJ Saad","year":"1995","unstructured":"Saad MJ, Hartmann LG, de Carvalho DS, Galoro CA, Brenelli SL, Carvalho CR (1995) Effect of glucagon on insulin receptor substrate-1 (IRS-1) phosphorylation and association with phosphatidylinositol 3-kinase (PI 3-kinase). FEBS Lett 370:131\u2013134","journal-title":"FEBS Lett"},{"key":"2801_CR48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cmet.2011.09.006","volume":"14","author":"B Thorens","year":"2011","unstructured":"Thorens B (2011) Of fat, beta cells, and diabetes. Cell Metab 14:439\u2013440","journal-title":"Cell Metab"},{"key":"2801_CR49","unstructured":"www.fda.gov\/drugs\/drugsafety\/ucm300889.htm , last accessed, 8 November, 2012"},{"key":"2801_CR50","doi-asserted-by":"crossref","unstructured":"Parving HH, Brenner BM, McMurray JJ et al (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. doi: 10.1056\/NEJMoa1208799","DOI":"10.1056\/NEJMoa1208799"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2801-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-012-2801-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2801-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T04:57:06Z","timestamp":1562475426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-012-2801-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,19]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2801"],"URL":"https:\/\/doi.org\/10.1007\/s00125-012-2801-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,19]]}}}